Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 11, 2015 - Issue
Submit an article Journal homepage
98
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension

Shusuke Yagi1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, JapanCorrespondence[email protected]
,
Akira Takashima1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Minoru Mitsugi2 Department of Internal Medicine, Shikoku Central Hospital, Shikokuchuo, Japan
,
Toshihiro Wada2 Department of Internal Medicine, Shikoku Central Hospital, Shikokuchuo, Japan
,
Junko Hotchi1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Ken-ichi Aihara3 Department of Medicine and Bioregulatory Sciences, University of Tokushima, Tokushima, Japan
,
Tomoya Hara1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Masayoshi Ishida1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Daiju Fukuda4 Department of Cardio-Diabetes Medicine, University of Tokushima, Tokushima, Japan
,
Takayuki Ise1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Koji Yamaguchi1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Takeshi Tobiume1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Takashi Iwase1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Hirotsugu Yamada1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Takeshi Soeki1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Tetsuzo Wakatsuki1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
,
Michio Shimabukuro4 Department of Cardio-Diabetes Medicine, University of Tokushima, Tokushima, Japan
,
Masashi Akaike5 Department of Medical Education, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
&
Masataka Sata1 Department of Cardiovascular Medicine, Graduate School of Health Biosciences, University of Tokushima, Tokushima, Japan
 show all
Pages 83-88 | Published online: 12 Jan 2015

References

  • FujiyoshiAOhkuboTMiuraKObservational Cohorts in Japan (EPOCH-JAPAN) Research GroupBlood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and womenHypertens Res201235994795322739419
  • HozawaAOhkuboTKikuyaMBlood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: the Ohasama studyHypertens Res2002251576311924727
  • MoriHUkaiHYamamotoHCurrent status of antihypertensive prescription and associated blood pressure control in JapanHypertens Res200629314315116755149
  • JamesPAOparilSCarterBL2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)JAMA2014311550752024352797
  • NwankwoTYoonSSBurtVGuQHypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012NCHS Data Brief20131331824171916
  • EganBMZhaoYAxonRNUS trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008JAMA2010303202043205020501926
  • ChapmanRHBennerJSPetrillaAAPredictors of adherence with antihypertensive and lipid-lowering therapyArch Intern Med2005165101147115215911728
  • MazzagliaGAmbrosioniEAlacquaMAdherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patientsCirculation2009120161598160519805653
  • OgiharaTKikuchiKMatsuokaHThe Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)Hypertens Res3202014 [Epub ahead of print]
  • StaessenJAWangJGThijsLCardiovascular protection and blood pressure reduction: a meta-analysisLancet200135892901305131511684211
  • OgawaHKim-MitsuyamaSMatsuiKAngiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patientsAm J Med20121251098199022503610
  • LawMRWaldNJMorrisJKJordanREValue of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBMJ20033267404142712829555
  • YiannakopoulouEPapadopulosJSCokkinosDVMountokalakisTDAdherence to antihypertensive treatment: a critical factor for blood pressure controlEur J Cardiovasc Prev Rehabil200512324324915942423
  • GustafssonDUnwinRThe pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortalityBMC Nephrol20131416423895142
  • WangJGStaessenJAFagardRHBirkenhagerWHGongLLiuLPrognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertensionHypertension20013741069107411304505
  • BosMJKoudstaalPJHofmanAWittemanJCBretelerMMUric acid is a risk factor for myocardial infarction and stroke – The Rotterdam StudyStroke20063761503150716675740
  • CorryDBEslamiPYamamotoKNybyMDMakinoHTuckMLUric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin systemJ Hypertens200826226927518192841
  • HamadaTIchicaKHosoyamadaMUricosuric action of losartan via the inhibition of urate transporter 1 (URAT1) in hypertensive patientsAm J Hypertens200821101157116218670416
  • NakamuraMAnzaiNJutabhaPSatoHSakuraiHIchidaKConcentration-dependent inhibitory effect of irbesartan on renal uric acid transportersJ Pharmacol Sci2010114111511820736511
  • ParhoferKGMunzelFKreklerMEffect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational studyCardiovasc Diabetol200763618042288
  • De LuisDACondeRGonzalez SagradoMEffects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese womenEur Rev Med Pharmacol Sci201014975976321061834

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.